Nathalie Texier

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Persistent uncontrolled severe asthma despite widespread biologic use: care gaps from the French FASE2-CPHG real-world study.

Persistent uncontrolled severe asthma despite widespread biologic use: care gaps from the French FASE2-CPHG real-world study.

Journal: The journal of allergy and clinical immunology. In practice

Published: February 09, 2026

Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON Study.

Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON Study.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Effects of alcohol misuse on the evolution of anxiety during the COVID-19 pandemic in France: results from CONFINS cohort.

Effects of alcohol misuse on the evolution of anxiety during the COVID-19 pandemic in France: results from CONFINS cohort.

Journal: BMJ open

Published: January 07, 2026

How Social Media Analysis Offers an Opportunity to Understand the Reality of People Living With Multiple Sclerosis: Descriptive French Study.

How Social Media Analysis Offers an Opportunity to Understand the Reality of People Living With Multiple Sclerosis: Descriptive French Study.

Journal: JMIR infodemiology

Published: December 01, 2025

Impact of Natalizumab on Productivity and Ability to Work in Patients with Multiple Sclerosis in France: The TITAN Study.

Impact of Natalizumab on Productivity and Ability to Work in Patients with Multiple Sclerosis in France: The TITAN Study.

Journal: Neurology and therapy

Published: December 03, 2024

Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti-CD38 Antibodies: The EMMY Cohort From 2017 to 2020.

Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti-CD38 Antibodies: The EMMY Cohort From 2017 to 2020.

Journal: Cancer medicine

Published: October 04, 2024

Evaluation of BERT-Based Models on Patient Data from French Social Media.

Evaluation of BERT-Based Models on Patient Data from French Social Media.

Journal: Studies in health technology and informatics

Published: August 23, 2024

TEC-ADHERE: Real-World Persistence and Adherence on Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis in the French OroSEP Patient-Support Program.

TEC-ADHERE: Real-World Persistence and Adherence on Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis in the French OroSEP Patient-Support Program.

Journal: Neurology and therapy

Published: June 26, 2024

The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emerge.

The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emerge.

Journal: Clinical hematology international

Published: April 04, 2024

Correction to: Factors related to increased alcohol misuse by students compared to non-students during the first Covid-19 lockdown in France: the confins study.

Correction to: Factors related to increased alcohol misuse by students compared to non-students during the first Covid-19 lockdown in France: the confins study.

Journal: BMC public health

Published: March 13, 2024

Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real-world setting: The ALFA study.

Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real-world setting: The ALFA study.

Journal: European journal of haematology

Published: December 14, 2023

Real-life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study.

Real-life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study.

Journal: EJHaem

Published: September 15, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026